Monopar Therapeutics Inc. announced that Dr. Andrew P. Mazar, the Company's Co-Founder, Executive Vice President of Research and Development, Chief Scientific Officer and Board Member, will be resigning from his position with the Company and as a member of the Company's Board of Directors effective April 8, 2022.